A detailed history of Nfp Retirement, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Nfp Retirement, Inc. holds 3,908 shares of ABBV stock, worth $753,735. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,908
Previous 3,532 10.65%
Holding current value
$753,735
Previous $698 Million 0.47%
% of portfolio
0.05%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$164.99 - $203.87 $62,036 - $76,655
376 Added 10.65%
3,908 $694 Million
Q3 2024

Feb 13, 2025

SELL
$163.84 - $199.33 $2,621 - $3,189
-16 Reduced 0.45%
3,532 $698 Million
Q2 2024

Feb 13, 2025

SELL
$154.79 - $180.76 $21,051 - $24,583
-136 Reduced 3.69%
3,548 $609 Million
Q1 2024

Feb 13, 2025

BUY
$159.82 - $182.1 $15,982 - $18,210
100 Added 2.79%
3,684 $670 Million
Q4 2023

Feb 13, 2025

BUY
$137.6 - $154.97 $13,897 - $15,651
101 Added 2.9%
3,584 $555 Million
Q2 2023

Feb 13, 2025

SELL
$132.51 - $164.9 $4,637 - $5,771
-35 Reduced 0.99%
3,483 $469 Million
Q1 2023

Feb 13, 2025

SELL
$144.61 - $166.54 $2,458 - $2,831
-17 Reduced 0.48%
3,518 $561 Million
Q4 2022

Feb 13, 2025

SELL
$138.31 - $165.87 $37,896 - $45,448
-274 Reduced 7.19%
3,535 $571 Million
Q3 2022

Feb 13, 2025

SELL
$134.21 - $153.93 $1,744 - $2,001
-13 Reduced 0.34%
3,809 $511 Million
Q2 2022

Feb 13, 2025

BUY
$137.62 - $174.96 $13,899 - $17,670
101 Added 2.71%
3,822 $585 Million
Q1 2022

Feb 13, 2025

BUY
$131.98 - $163.75 $249,706 - $309,815
1,892 Added 103.44%
3,721 $603 Million
Q4 2021

Feb 13, 2025

BUY
$107.43 - $135.93 $196,489 - $248,615
1,829 New
1,829 $248 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nfp Retirement, Inc. Portfolio

Follow Nfp Retirement, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nfp Retirement, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nfp Retirement, Inc. with notifications on news.